Challenges for the implementation of injectable opioid agonist treatment: a scoping review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Challenges for the implementation of injectable opioid agonist treatment: a scoping review ; volume:21 ; number:1 ; day:4 ; month:12 ; year:2024 ; pages:1-24 ; date:12.2024
Harm reduction journal ; 21, Heft 1 (4.12.2024), 1-24, 12.2024
- Classification
-
Medizin, Gesundheit
- Creator
-
Schwarz, Tanja
Akartuna, Deniz
Busch, Martin
Krausz, R. Michael
Uhl, Alfred
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12954-024-01102-x
- URN
-
urn:nbn:de:101:1-2502182125284.730873766795
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schwarz, Tanja
- Akartuna, Deniz
- Busch, Martin
- Krausz, R. Michael
- Uhl, Alfred
- SpringerLink (Online service)
Other Objects (12)
Exploring Patients’ Perceptions on Injectable Opioid Agonist Treatment: Influences on Treatment Initiation and Implications for Practice
Better agonist for the opioid receptors
Alcohol use in opioid agonist treatment
Interim opioid agonist treatment for opioid addiction: a systematic review
Shared decision-making and client-reported dose satisfaction in a longitudinal cohort receiving injectable opioid agonist treatment (iOAT)
Clients’ experiences on North America’s first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study
Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study
![Agonist-selektive Phosphorylierung und Dephosphorylierung des μ-Opioid-Rezeptors [My-Opioid-Rezeptors]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Agonist-selektive Phosphorylierung und Dephosphorylierung des μ-Opioid-Rezeptors [My-Opioid-Rezeptors]
“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises
Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment
Implementation strategies to scale up self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception: a scoping review
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
Exploring Patients’ Perceptions on Injectable Opioid Agonist Treatment: Influences on Treatment Initiation and Implications for Practice
Better agonist for the opioid receptors
Alcohol use in opioid agonist treatment
Interim opioid agonist treatment for opioid addiction: a systematic review
Shared decision-making and client-reported dose satisfaction in a longitudinal cohort receiving injectable opioid agonist treatment (iOAT)
Clients’ experiences on North America’s first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study
Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study
Agonist-selektive Phosphorylierung und Dephosphorylierung des μ-Opioid-Rezeptors [My-Opioid-Rezeptors]
“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises
Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment
Implementation strategies to scale up self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception: a scoping review
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
Exploring Patients’ Perceptions on Injectable Opioid Agonist Treatment: Influences on Treatment Initiation and Implications for Practice
Better agonist for the opioid receptors
Alcohol use in opioid agonist treatment
Interim opioid agonist treatment for opioid addiction: a systematic review
Shared decision-making and client-reported dose satisfaction in a longitudinal cohort receiving injectable opioid agonist treatment (iOAT)
Clients’ experiences on North America’s first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study
Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study
Agonist-selektive Phosphorylierung und Dephosphorylierung des μ-Opioid-Rezeptors [My-Opioid-Rezeptors]
“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises
Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment
Implementation strategies to scale up self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception: a scoping review